Previous Article | Next Article ![]()
J. Virol., 07 1996, 4632-4645, Vol 70, No. 7
DR Anderson, JE Wilson, CM Carthy, D Yang, R Kandolf and BM McManus
In vitro replication of coxsackievirus B3 (CVB3) in cells of the immune
system derived from uninfected adolescent A/J and C57BL/6J mice and
replication of CVB3 in and association with immune cells from spleens of
infected animals in vivo were assessed. Nonstimulated or mitogen-
stimulated spleen cells were minimally permissive for viral replication
during an 8-h period. Three days postinfection (p.i.), CVB3 RNA was
localized in vivo to B cells and follicular dendritic cells of germinal
centers in both A/J and C57BL/6J mice; however, extrafollicular
localization was greater in C57BL/6J mice (P = 0.0054). Although the
pattern of CVB3 RNA localization was different, the total load of
infections virus (PFU per milligram of tissue) was not different. Splenic
CVB3 titers (PFU per milligram of tissue) in both strains were maximal at
day 3 or 4 p.i. and were back to baseline by day 7 p.i., with most
infectious virus being non-cell associated. CVB3 titers (PFU per milligram
of tissue) correlated directly with in situ hybridization positivity in
splenic follicles and extrafollicular regions in both murine strains;
however, follicular hybridization intensity was greater in A/J mice at day
5 p.i. (P = 0.021). Flow cytometric analysis demonstrated that 50.4% of
total spleen cells positive for CVB3 antigen were B cells and 69.6% of
positive splenic lymphocytes were B cells. Myocardial virus load in
C57BL/6J mice was significantly lower than that in A/J mice at days 4 and 5
p.i. These data indicate that CVB3 replicates in murine splenocytes in
vitro and in B cells and extrafollicular cells in vivo.
Copyright © 1996, American Society for Microbiology
Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis
Department of Pathology and Laboratory Medicine, University of British Columbia-St. Paul's Hospital, Vancouver, Canada.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|